EU Evaluates Authorization Renewal Application for Genetically Modified Maize MON 810

In a recent development, the European Food Safety Authority (EFSA) has assessed the authorization renewal application for genetically modified maize MON 810 in the European Union (EU). This evaluation by the EFSA's Panel on Genetically Modified Organisms (GMO) aims to determine whether there are any new risks or uncertainties associated with MON 810.

The European Union has taken a significant step in evaluating the authorization renewal application for the genetically modified maize MON 810. On January 19, 2024, the EFSA announced that its GMO Panel had conducted a comprehensive assessment of the application.

Following a thorough evaluation, the GMO Panel concluded that the application, identified as GMFF-2022-9450, does not provide evidence of new hazards, modified exposure levels, or scientific uncertainties that would alter the original risk assessment conducted on MON 810. This means that the current conclusions regarding the safety of MON 810 remain unchanged.

The renewal application, submitted by Bayer Agriculture BV under Regulation (EC) No 1829/2003, requested authorization for the continued use of MON 810 for food and feed purposes, excluding cultivation within the EU. The application included various data sources such as post-market environmental monitoring reports, literature evaluations, additional studies, and updated bioinformatics analyses.

The EFSA's evaluation focused on assessing potential new risks or uncertainties that may have arisen since the original authorization. It is important to note that the evaluation assumes the DNA sequence of MON 810 in the renewal application is identical to the initially assessed event.

The outcome of this evaluation is significant for both stakeholders and consumers. The conclusion that there are no new risks associated with MON 810 provides support for the continued use of this genetically modified maize in the EU's food and feed supply chain. It reinforces the existing risk assessment and contributes to the ongoing dialogue surrounding genetically modified organisms (GMOs) in Europe.

The EU's evaluation of the authorization renewal application for genetically modified maize MON 810 has determined that there is no evidence to suggest new hazards, modified exposure levels, or scientific uncertainties compared to the original risk assessment. This evaluation by the EFSA's GMO Panel reaffirms the safety of MON 810 for food and feed purposes within the European Union. As the discussion on GMOs continues, this evaluation contributes to the broader understanding of genetically modified crops and their role in the EU's agricultural landscape.